The Judgment of Paris: treatment dilemmas in advanced renal cell carcinoma

MeSH terms

• Angiogenesis Inhibitors / therapeutic use*
• Biopsy
• Carcinoma, Renal Cell / blood supply
• Carcinoma, Renal Cell / enzymology
• Carcinoma, Renal Cell / secondary
• Carcinoma, Renal Cell / therapy*
• Disease Progression
• Fatal Outcome
• Humans
• Kidney Neoplasms / blood supply
• Kidney Neoplasms / enzymology
• Kidney Neoplasms / pathology
• Kidney Neoplasms / therapy*
• Liver Neoplasms / secondary
• Lung Neoplasms / blood supply
• Lung Neoplasms / drug therapy*
• Lung Neoplasms / enzymology
• Lung Neoplasms / secondary
• Male
• Middle Aged
• Molecular Targeted Therapy
• Neoplasm Grading
• Neoplasm Staging
• Nephrectomy*
• Patient Selection
• Precision Medicine
• Protein Kinase Inhibitors / therapeutic use*
• Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
• Receptors, Vascular Endothelial Growth Factor / metabolism
• TOR Serine-Threonine Kinases / antagonists & inhibitors
• TOR Serine-Threonine Kinases / metabolism
• Time Factors
• Tomography, X-Ray Computed
• Treatment Outcome
• Tumor Burden